FCF yield společnosti OncoSec Medical Inc
Jaká je hodnota metriky FCF yield společnosti OncoSec Medical Inc?
Hodnota metriky FCF yield společnosti OncoSec Medical Inc je -483.57%
Jaká je definice metriky FCF yield?
Free cash flow yield (FCF yield) is a financial ratio that compares the free cash flow per share to the market value per share. The ratio is calculated by dividing free cash flow per share by the current share price.
ttm (trailing twelve months)
Free cash flow yield is a good measure of the company’s cash flow in respect to the company’s size. Larger companies tend to have a higher cash flow yield, but it’s not always the case. The higher the free cash flow yield, the more cash the company is generating that can be quickly accessed to satisfy its obligations. The lower the free cash flow yield, the more money investors are putting into the company with little result. The higher the ratio, the more attractive the investment is as it suggests that investors are paying less for each unit of free cash flow.
Free cash flow acts as an indicator of how capable a company is of repaying all of its obligations. It is a solid indicator of how financially stable a company is. It is calculated as:
Free cash flow yield = Free cash flow per share / market price per share
FCF yield společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností OncoSec Medical Inc
Čemu se věnuje společnost OncoSec Medical Inc?
oncosec is a san diego-based biotechnology company pioneering new technologies to stimulate the body’s immune system to target and attack cancer. through our proprietary technology, we hope to deliver safer and more effective cancer treatments that can provide long-term benefits for patients. our technology, immunopulse™, is designed to enhance the local delivery and uptake of dna-based immune-targeting agents, such as il-12. clinical trials of immunopulse™ il-12 demonstrated a favorable safety profile and evidence of anti-tumor activity in the treatment of various skin cancers as well as the potential to initiate a systemic immune response. our lead program, immunopulse™ il-12, is currently in phase ii development for several indications, including metastatic melanoma, squamous cell carcinoma of the head and neck, and triple-negative breast cancer. to date, study results have laid the groundwork for the expansion into new dna-encoded therapeutic candidates and tumor indications. we ar
Firmy s metrikou fcf yield podobnou společnosti OncoSec Medical Inc
- Hodnota metriky FCF yield společnosti Winc je -518.19%
- Hodnota metriky FCF yield společnosti Exicure je -510.85%
- Hodnota metriky FCF yield společnosti Shopify je -498.72%
- Hodnota metriky FCF yield společnosti Cuda Oil and Gas je -496.54%
- Hodnota metriky FCF yield společnosti BBVA Argentina je -486.90%
- Hodnota metriky FCF yield společnosti Waitr Inc je -485.61%
- Hodnota metriky FCF yield společnosti OncoSec Medical Inc je -483.57%
- Hodnota metriky FCF yield společnosti Kiromic BioPharma je -482.25%
- Hodnota metriky FCF yield společnosti NextDecade je -481.51%
- Hodnota metriky FCF yield společnosti Silver Mountain Mines je -481.33%
- Hodnota metriky FCF yield společnosti Skyfame Realty () je -477.89%
- Hodnota metriky FCF yield společnosti EVIO je -476.77%
- Hodnota metriky FCF yield společnosti Shift Technologies je -471.17%